Mr. Chua Ser Miang
Non-Executive Chairman and Independent Director
Board of DirectorsThe business, the people and the ownership behind Aoxin Q & M.
Business overview
Aoxin Q & M Dental Group provides private dental healthcare services in Liaoning Province, China. It operates dental hospitals and polyclinics across several cities, including Shenyang, Huludao, Panjin, Gaizhou, Zhuanghe, Jinzhou and Dalian.
Listed security
Board & management
Non-Executive Chairman and Independent Director
Board of DirectorsIndependent Director
Board of DirectorsIndependent Director
Board of DirectorsIndependent Director
Board of DirectorsNon-Executive and Non-Independent Director
Board of DirectorsNon-Executive and Non-Independent Director
Board of DirectorsRoles listed in ANNUAL REPORT 2025; current appointments are not independently verified.
Holdings
Direct: 538,579,592 shares (52.64%); Deemed: – (–)
Substantial shareholders; % based on 1,023,044,096 sharesDirect: 5,125,600 shares (0.50%); Deemed: 538,579,592 shares (52.64%)
Substantial shareholders; % based on 1,023,044,096 sharesDirect: 326,600 shares (0.03%); Deemed: 543,725,192 shares (53.15%)
Substantial shareholders; % based on 1,023,044,096 sharesTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-20 · PDF p. 105
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| Q & M DENTAL GROUP (SINGAPORE) LIMITED | 538,579,592 shares (52.64%) | PDF p. 1052026-03-20 | |
| DBS NOMINEES PTE LTD | 65,342,164 shares (6.39%) | PDF p. 1052026-03-20 | |
| ONG SIEW HWA (WANG XIUHUA) | 46,327,318 shares (4.53%) | PDF p. 1052026-03-20 | |
| LIM AND TAN SECURITIES PTE LTD | 43,251,600 shares (4.23%) | PDF p. 1052026-03-20 | |
| MAYBANK SECURITIES PTE. LTD. | 28,093,500 shares (2.75%) | PDF p. 1052026-03-20 | |
| ABN AMRO CLEARING BANK N.V. | 24,125,600 shares (2.36%) | PDF p. 1052026-03-20 | |
| PHILLIP SECURITIES PTE LTD | 23,332,726 shares (2.28%) | PDF p. 1052026-03-20 | |
| TIGER BROKERS (SINGAPORE) PTE. LTD. | 21,562,100 shares (2.11%) | PDF p. 1052026-03-20 | |
| HEALTH FIELD ENTERPRISES LIMITED | 21,428,229 shares (2.09%) | PDF p. 1052026-03-20 | |
| CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. | 17,528,000 shares (1.71%) | PDF p. 1052026-03-20 | |
| LIM KUO KAE | 17,350,000 shares (1.70%) | PDF p. 1052026-03-20 | |
| OCBC SECURITIES PRIVATE LTD | 15,805,840 shares (1.54%) | PDF p. 1052026-03-20 | |
| ONG GIM LOO | 15,800,000 shares (1.54%) | PDF p. 1052026-03-20 | |
| LIM YONG LUY | 11,270,400 shares (1.10%) | PDF p. 1052026-03-20 | |
| FINEST INTERNATIONAL LIMITED | 10,516,320 shares (1.03%) | PDF p. 1052026-03-20 | |
| LOW CHUI HENG | 10,300,000 shares (1.01%) | PDF p. 1052026-03-20 | |
| UOB KAY HIAN PTE LTD | 9,591,913 shares (0.94%) | PDF p. 1052026-03-20 | |
| MOUNTAIN LIMITED | 7,265,605 shares (0.71%) | PDF p. 1052026-03-20 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 6,077,700 shares (0.59%) | PDF p. 1052026-03-20 | |
| EXCELLENT WARSHIP INTERNATIONAL LIMITED | 5,502,969 shares (0.54%) | PDF p. 1052026-03-20 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| Shenyang Xinao Hospital Management Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Heping Q & M Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Huludao City Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Huludao Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Quanxin Medical Equipment Leasing Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Panjin Jinsai Q & M Stomatology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Panjin Jingcheng Q & M Stomatology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 87 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Gaizhou City Aoxin Q & M Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Zhuanghe City Aoxin Dawei Dental Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Panjin Aoxin Quanmin Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Maotai Q & M Medical Equipment Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Shengtai Shenmao Trading Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Qingaomei Oral Restorative Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Qicheng (Shenyang) Digital Intelligent Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Quanao Medical Investment Management Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 99% (2025); 99% (2024); held through subsidiaries | |
| Shenyang Shenhe Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Dalian Aoxin Quanmin Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Huludao Longgang District Aoxin Stomatology Polyclinic Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Jinzhou Aoxin Youxin Dental Stomatology Hospital Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
| Shenyang Xinchuang Medical Technology Co., Ltd.Held through subsidiaries; 2025 vs 2024PDF p. 88 | PRC; effective equity held 100% (2025); 100% (2024); held through subsidiaries | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| DR. BAI YI | GENERAL MANAGER | PDF p. 13 | |
| MR. CUI GUOAN | CHIEF OPERATING OFFICER CUM DEPUTY CHIEF EXECUTIVE OFFICER | PDF p. 13 | |
| DR. JIA DAWEI | DEPUTY CHIEF EXECUTIVE OFFICER | PDF p. 13 | |
| MS. WANG JIE | DEPUTY CHIEF EXECUTIVE OFFICER | PDF p. 13 | |
| MR. YUE WEI | DEPUTY CHIEF EXECUTIVE OFFICER | PDF p. 14 | |
| MR. LOO KEAT CHOON | FINANCIAL CONTROLLER | PDF p. 14 | |
| MR. HUANG ZHENXING | DEPUTY GENERAL MANAGER | PDF p. 14 | |
| MR. ZHANG DONGWEI | DEPUTY GENERAL MANAGER (FINANCE) | PDF p. 14 |
Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Singapore Dental Cadcam Laboratory Pte. Ltd. | S$716,000* | FY2025 Rule 907 IPT; revenue from laboratory services segment; subsidiary of Q & M Dental Group (Singapore) Limited, a controlling shareholder | PDF p. 41 |
| Singapore Dental Cadcam Laboratory Pte. Ltd. | S$2,000* | FY2025 Rule 907 IPT; management fee income | PDF p. 41 |
| Singapore Dental Cadcam Laboratory Pte. Ltd. | S$156,000* | FY2025 Rule 907 IPT; other expenses | PDF p. 41 |
| Revenue from laboratory services | 3,939 RMB'000 | Group, 2025 (comparative 2024: 2,588) | PDF p. 73 |
| Management fee expenses | (660) RMB'000 | Group, 2025 (comparative 2024: (467)) | PDF p. 73 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Salaries and other short-term employee benefits | 4,355 RMB'000 | Group, 2025 (comparative 2024: 4,268) | PDF p. 73 |
| Directors' fees total | S$295,750 | FY2025 total Directors' fees | PDF p. 33 |
| Mr. Chua Ser Miang | 85,000 S$ | FY2025 total remuneration, S$ (all directors table; fees only) | PDF p. 33 |
| aggregate remuneration paid to all the key management personnel | approximately S$457,000 | FY2025, eight key management personnel who are not Directors or Group CEO | PDF p. 33 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Placement agreements | up to 84,000,000 Placement Shares at an issue price of S$0.1566 for each Placement Share | Events after reporting period, Note 33(a) | PDF p. 103 |
| Performance shares | 45,000,000 performance shares will be awarded to a selected group of high-performing employees | Events after reporting period, Note 33(b) · As at 2026-03-02 | PDF p. 103 |
| Cessation of operation of Panjin Aoxin Quanmin Stomatology Hospital Co., Ltd | the Board of Directors approved the closure of Panjin Hospital upon the expiry of its lease in April 2026 | Events after reporting period, Note 33(c) · As at 2026-03-23 | PDF p. 104 |
| Memorandum of understanding | non-binding MOU in relation to the proposed acquisition of 100% equity interest in a dental group based in central of PRC | Events after reporting period, Note 33(d) · As at 2026-03-25 | PDF p. 104 |
Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Corporate information